KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Revenue: 2009-2024

Historic Revenue for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $6.2 million.

  • Arbutus Biopharma's Revenue fell 60.49% to $529,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 116.64%. This contributed to the annual value of $6.2 million for FY2024, which is 65.98% down from last year.
  • Per Arbutus Biopharma's latest filing, its Revenue stood at $6.2 million for FY2024, which was down 65.98% from $18.1 million recorded in FY2023.
  • Over the past 5 years, Arbutus Biopharma's Revenue peaked at $39.0 million during FY2022, and registered a low of $6.2 million during FY2024.
  • Over the past 3 years, Arbutus Biopharma's median Revenue value was $18.1 million (recorded in 2023), while the average stood at $21.1 million.
  • As far as peak fluctuations go, Arbutus Biopharma's Revenue spiked by 255.11% in 2022, and later plummeted by 65.98% in 2024.
  • Arbutus Biopharma's Revenue (Yearly) stood at $6.9 million in 2020, then skyrocketed by 58.92% to $11.0 million in 2021, then soared by 255.11% to $39.0 million in 2022, then tumbled by 53.51% to $18.1 million in 2023, then slumped by 65.98% to $6.2 million in 2024.